Veterinary Infectious Disease Diagnostics Market to Reach $2.40 Bn, Globally, by 2026 at 8.3% CAGR: Allied Market Research

Increase in ownership of companion animals, surge in animal health expenditure, and demand for pet insurance drive the global veterinary infectious disease diagnostics market

PORTLAND, Oregon, April 13, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Veterinary Infectious Disease Diagnostics Market, by Product Type (Immunodiagnostics, Molecular Diagnostics, and Others) and Application (Dogs, Cats, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026." According to the report, the global veterinary infectious disease diagnostics industry garnered $1.27 billion in 2018, and is estimated to reach $2.40 billion by 2026, growing at a CAGR of 8.3% from 2019 to 2026.

Prime determinants of growth

Increase in ownership of companion animals, surge in animal health expenditure, and demand for pet insurance drive the global veterinary infectious disease diagnostics market. However, lack of veterinary infrastructure in underdeveloped countries hinders the market growth. On the other hand, rise in awareness regarding animal healthcare across the world create new opportunities in coming years.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6462

The immunodiagnostics segment to maintain its leadership position by 2026

Based on product type, the immunodiagnostics segment contributed to nearly half of the total share of the global veterinary infectious disease diagnostics market in 2018, and is expected to maintain its leadership position throughout the forecast period. Moreover, this segment would portray the highest CAGR of 9.2% from 2019 to 2026.This is due to benefits related to utilization of these tests including rapid results and accurate diagnosis.The research also analyzes segments including molecular diagnostics and others.

The dogs segment to maintain its lion's share in terms of revenue by 2026

Based on application, the dogs segment accounted for the largest market share of the global veterinary infectious disease diagnostics market, accounting for more than two-fifths of the total market share in 2018, and is expected to maintain its lion's share in terms of revenue by 2026. Moreover, this segment is estimated to grow at the highest CAGR of 9.0% from 2019 to 2026. This is due to increase in ownership of dogs as companion animals across the world.The report also discusses segments including cats and others.

North America to maintain its dominance during the forecast period

Based on region, North America accounted for the highest market share in terms of revenue, accounting for nearly two-fifths of the global veterinary infectious disease diagnostics market in 2018, and is estimated to maintain its dominance during the forecast period. This is attributed to rise in awareness regarding early screening of diseases in companion animals and availability of better veterinary treatment options.Moreover, Asia-Pacific is expected to maintain the highest CAGR of 10.3% from 2019 to 2026, owing to increase in pet ownership and surge in awareness regarding early diagnosing and treatment of diseases occurring in companion animals.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6462

Leading market players

• Biomérieux SA
• HESKA Corporation
• IDEXX Laboratories, Inc.
• ID.Vet
• Neogen Corporation
• Qiagen N.V.
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Virbac
• Zoetis

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information:https://www.alliedmarketresearch.com/library-access

Similar Reports:

Companion Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

DNA Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

Digital Diabetes Management Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

Pharmaceutical Drug Delivery Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

Tampon Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Web:https://www.alliedmarketresearch.com

Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg